AssetID: 55230303
Headline: FDA Moves To Speed Up Approval Of Generic Biologic Drugs To Cut Health Costs
Caption: The US Food and Drug Administration is set to streamline how generic versions of complex biological drugs, known as biosimilars are approved, in a move aimed at lowering healthcare costs and boosting competition
Keywords: Health & Wellbeing,Speed Up,Approval,Generic,Biologic,Drugs,Health,Costs,Cut,Boosting,Competition,Biosimilars,Healthcare,US,United States,Pills
PersonInImage: